CNC
Centene Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+34/100
Last price
64.61
▲ 0.31 (0.48%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
64.00
Prev close
64.30
Day high
64.76
Day low
63.61
Volume
3.66M
Market cap
$31.92B
P/E (TTM)
—
52W range
31.63 – 69.63
Day trading desk
Gap from prior close
-0.47%
Prior close 64.30
VWAP
64.38
+0.36% from price
Relative volume
1.70×
Unusually busy
Session range
1.82%
63.60 – 64.76
Position in range
87%
Near session high
ATR (14D)
1.89
2.93% of price
Prior day high
64.34
PDH
Prior day low
62.93
PDL
Bid / ask spread
—
Quote not published
Session volume
7.72M
Avg 4.55M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.86%
+1.9%
1M
-3.62%
-4.8%
3M
-3.70%
-8.2%
6M
+77.94%
+59.8%
YTD
+57.01%
+42.8%
1Y
+66.95%
+50.5%
3Y
-6.20%
-88.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CNC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-137.96K
Net selling
Buy transactions
20
46.14K shares
Sell transactions
3
184.10K shares
Net transactions
+23
Buys less sells
Sell : buy shares
4.0 : 1
Mixed
Insider-held shares
1.95M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 30, 26 | SAMUELS THEODORE R II Director |
STOCK | 583 | $0 | Direct |
| Sep 30, 26 | TANJI KENNETH Y. Director |
STOCK | 603 | $0 | Direct |
| Sep 30, 26 | EPPINGER FREDERICK H Director |
STOCK | 864 | $0 | Direct |
| Sep 30, 26 | TYLER LAUREN M. Director |
STOCK | 482 | $0 | Direct |
| Sep 30, 26 | COUGHLIN CHRISTOPHER J Director |
STOCK | 583 | $0 | Direct |
| Aug 26, 26 | KOSTER CHRISTOPHER A. General Counsel |
SELL | 56.50K | $3.78M | Direct |
| Aug 18, 26 | KOSTER CHRISTOPHER A. General Counsel |
SELL | 47.60K | $3.11M | Direct |
| Jul 28, 26 | DIAZ PAUL J Director |
STOCK | 2.77K | $0 | Direct |
| Jul 17, 26 | TYLER LAUREN M. Director |
STOCK | 3.15K | $0 | Direct |
| Jun 30, 26 | SAMUELS THEODORE R II Director |
STOCK | 465 | $0 | Direct |
| Jun 30, 26 | TANJI KENNETH Y. Director |
STOCK | 581 | $0 | Direct |
| Jun 30, 26 | EPPINGER FREDERICK H Director |
STOCK | 833 | $0 | Direct |
| Jun 30, 26 | TYLER LAUREN M. Director |
STOCK | 61 | $0 | Direct |
| Jun 30, 26 | COUGHLIN CHRISTOPHER J Director |
STOCK | 562 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ASHER ANDREW LYNN |
Chief Financial Officer | 831.22K | Stock Award(Grant) |
BURDICK KENNETH A |
Director | 283.58K | Sale |
CASSO KATIE |
Officer | 122.37K | Stock Award(Grant) |
DALLAS HIRAM JAMES |
Director | 49.57K | Stock Award(Grant) |
EPPINGER FREDERICK H |
Director | 370.40K | Stock Award(Grant) |
KOSTER CHRISTOPHER A. |
General Counsel | 248.95K | Sale |
LONDON SARAH M. |
Chief Executive Officer | 1.37M | Stock Award(Grant) |
MCNALLY TANYA M |
Officer | 133.08K | Stock Award(Grant) |
SAMUELS THEODORE R II |
Director | 57.80K | Stock Award(Grant) |
SMITH SUSAN RAYE |
Chief Operating Officer | 225.29K | Stock Award(Grant) |
Fundamentals
Market cap$31.92B
Enterprise value$21.06B
Revenue (TTM)$180.30B
Gross profit$20.58B
EBITDA$4.61B
Net income$-5.10B
EPS (TTM)$-10.44
Free cash flow$9.64B
Total cash$27.06B
Total debt$16.10B
Book value / share$45.67
Shares outstanding494.00M
Float463.68M
Short % of float3.28%
Dividend yield0.00%
Beta (5Y)1.13
Valuation & profitability ratios
Trailing P/E—
Forward P/E12.08
PEG ratio0.78
Price / sales—
Price / book1.41
EV / revenue0.12
EV / EBITDA4.57
Gross margin11.42%
Operating margin3.76%
Profit margin-2.83%
Return on equity-20.36%
Return on assets2.48%
Debt / equity71.08
Current ratio1.15
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $194.78B | $163.07B | $154.00B | $144.55B | +19.4% |
| Operating revenue | $174.58B | $145.50B | $140.09B | $135.48B | +20.0% |
| Cost of revenue | $180.91B | $146.24B | $136.68B | $127.89B | +23.7% |
| Gross profit | $13.87B | $16.83B | $17.32B | $16.66B | -17.6% |
| Selling, general & admin | $12.90B | $12.40B | $12.56B | $11.59B | +4.1% |
| Total operating expense | $14.18B | $13.64B | $13.86B | $13.02B | +3.9% |
| Operating income | -$312.00M | $3.19B | $3.46B | $3.64B | -109.8% |
| Net interest income | -$678.00M | -$702.00M | -$725.00M | -$665.00M | +3.4% |
| Pre-tax income | -$6.73B | $4.26B | $3.60B | $1.96B | -258.0% |
| Tax provision | -$51.00M | $963.00M | $899.00M | $760.00M | -105.3% |
| Net income | -$6.67B | $3.31B | $2.70B | $1.20B | -301.9% |
| Net income to common | -$6.67B | $3.31B | $2.70B | $1.20B | -301.9% |
| Basic EPS | -13.53 | 6.33 | 4.97 | 2.09 | -313.7% |
| Diluted EPS | -13.53 | 6.31 | 4.95 | 2.07 | -314.4% |
| EBIT | -$6.05B | $4.96B | $4.32B | $2.63B | -222.0% |
| EBITDA | -$4.78B | $6.20B | $5.62B | $4.06B | -177.0% |
| Basic shares | 493.12M | 521.79M | 543.32M | 575.19M | -5.5% |
| Diluted shares | 493.12M | 523.74M | 545.70M | 582.04M | -5.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $17.89B | $14.06B | $17.19B | $12.07B | +27.2% |
| Cash & short-term investments | $20.32B | $16.68B | $19.65B | $14.39B | +21.8% |
| Accounts receivable | $18.11B | $19.71B | $15.53B | $13.27B | -8.2% |
| Total current assets | $40.37B | $38.00B | $40.76B | $30.13B | +6.2% |
| Property, plant & equipment | $2.35B | $2.43B | $2.42B | $4.99B | -3.0% |
| Goodwill & intangibles | $15.37B | $22.97B | $23.66B | $25.72B | -33.1% |
| Total assets | $76.75B | $82.44B | $84.64B | $76.87B | -6.9% |
| Total current liabilities | $36.70B | $34.26B | $36.72B | $28.46B | +7.1% |
| Current debt | $50.00M | $110.00M | $119.00M | $82.00M | -54.5% |
| Long-term debt | $17.35B | $18.42B | $17.71B | $17.94B | -5.8% |
| Total debt | $18.16B | $19.43B | $18.88B | $21.33B | -6.5% |
| Total liabilities | $56.69B | $55.94B | $58.69B | $52.63B | +1.4% |
| Retained earnings | $8.67B | $15.35B | $12.04B | $9.34B | -43.5% |
| Shareholder equity | $19.95B | $26.41B | $25.84B | $24.06B | -24.4% |
| Working capital | $3.67B | $3.74B | $4.04B | $1.66B | -1.7% |
| Net tangible assets | $4.59B | $3.44B | $2.18B | -$1.67B | +33.3% |
| Shares issued | 623.46M | 620.20M | 615.29M | 607.85M | +0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$6.68B | $3.29B | $2.70B | $1.20B | -302.7% |
| Depreciation & amortisation | $1.27B | $1.24B | $1.29B | $1.43B | +2.7% |
| Stock-based compensation | $204.00M | $212.00M | $216.00M | $234.00M | -3.8% |
| Change in working capital | $3.04B | -$4.50B | $3.55B | $2.32B | +167.5% |
| Operating cash flow | $5.09B | $154.00M | $8.05B | $6.26B | +3,203.9% |
| Capital expenditure | -$767.00M | -$644.00M | -$799.00M | -$1.00B | -19.1% |
| Investing cash flow | $472.00M | -$1.05B | -$1.19B | -$2.92B | +144.9% |
| Share buybacks | -$475.00M | -$3.12B | -$1.63B | -$3.10B | +84.8% |
| Financing cash flow | -$1.62B | -$2.41B | -$1.66B | -$4.20B | +32.6% |
| Free cash flow | $4.32B | -$490.00M | $7.25B | $5.26B | +981.8% |
| End cash position | $17.96B | $14.16B | $17.45B | $12.33B | +26.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $53.58B | $49.94B | $49.73B | $49.69B | $48.74B | +7.3% |
| Operating revenue | $44.38B | $44.66B | $44.73B | $44.90B | $42.47B | -0.6% |
| Cost of revenue | $48.98B | $44.39B | $47.26B | $46.44B | $45.80B | +10.3% |
| Gross profit | $4.60B | $5.56B | $2.47B | $3.25B | $2.95B | -17.2% |
| Selling, general & admin | $3.10B | $3.40B | $3.37B | $3.15B | $3.04B | -8.7% |
| Total operating expense | $3.40B | $3.70B | $3.70B | $3.46B | $3.35B | -8.0% |
| Operating income | $1.20B | $1.86B | -$1.23B | -$211.00M | -$403.00M | -35.6% |
| Net interest income | -$153.00M | -$164.00M | -$168.00M | -$170.00M | -$170.00M | +6.7% |
| Pre-tax income | $1.49B | $2.10B | -$1.54B | -$6.67B | -$257.00M | -29.2% |
| Tax provision | $399.00M | $560.00M | -$443.00M | -$42.00M | $2.00M | -28.7% |
| Net income | $1.09B | $1.54B | -$1.10B | -$6.63B | -$253.00M | -29.2% |
| Net income to common | $1.09B | $1.54B | -$1.10B | -$6.63B | -$253.00M | -29.2% |
| Basic EPS | 2.21 | 3.13 | -2.24 | -13.50 | -0.51 | -29.4% |
| Diluted EPS | 2.19 | 3.11 | -2.24 | -13.50 | -0.51 | -29.6% |
| EBIT | $1.64B | $2.26B | -$1.38B | -$6.50B | -$87.00M | -27.6% |
| EBITDA | $1.94B | $2.56B | -$1.05B | -$6.19B | $228.00M | -24.3% |
| Basic shares | 493.82M | 492.07M | 491.53M | 491.14M | 493.55M | +0.4% |
| Diluted shares | 497.64M | 495.59M | 491.53M | 491.14M | 493.55M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $24.15B | $21.26B | $17.89B | $17.06B | $14.51B | +13.6% |
| Cash & short-term investments | $27.06B | $23.74B | $20.32B | $19.24B | $17.28B | +14.0% |
| Accounts receivable | $18.08B | $19.43B | $18.11B | $23.11B | $21.55B | -6.9% |
| Total current assets | $46.69B | $44.99B | $40.37B | $44.06B | $40.39B | +3.8% |
| Property, plant & equipment | $2.13B | $2.09B | $2.35B | $2.16B | $2.12B | +1.9% |
| Goodwill & intangibles | $15.04B | $15.20B | $15.37B | $15.68B | $22.57B | -1.1% |
| Total assets | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | +2.3% |
| Total current liabilities | $40.76B | $40.05B | $36.70B | $40.63B | $36.79B | +1.8% |
| Current debt | $75.00M | $63.00M | $50.00M | $38.00M | $25.00M | +19.0% |
| Long-term debt | $16.03B | $16.31B | $17.35B | $17.55B | $17.55B | -1.7% |
| Total debt | $16.11B | $16.37B | $18.16B | $17.58B | $17.58B | -1.6% |
| Total liabilities | $60.35B | $59.65B | $56.69B | $61.03B | $58.89B | +1.2% |
| Retained earnings | $11.31B | $10.21B | $8.67B | $9.78B | $16.41B | +10.7% |
| Shareholder equity | $22.56B | $21.43B | $19.95B | $20.95B | $27.41B | +5.3% |
| Working capital | $5.93B | $4.94B | $3.67B | $3.43B | $3.60B | +19.9% |
| Net tangible assets | $7.52B | $6.23B | $4.59B | $5.27B | $4.84B | +20.8% |
| Shares issued | 493.99M | 625.48M | 623.46M | 623.12M | 622.83M | -21.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.09B | $1.54B | -$1.10B | -$6.63B | -$259.00M | -29.4% |
| Depreciation & amortisation | $300.00M | $300.00M | $329.00M | $317.00M | $315.00M | 0.0% |
| Stock-based compensation | $59.00M | $67.00M | $58.00M | $52.00M | $35.00M | -11.9% |
| Change in working capital | $2.13B | $2.51B | $723.00M | $747.00M | $1.73B | -15.0% |
| Operating cash flow | $3.59B | $4.37B | $437.00M | $1.36B | $1.78B | -17.8% |
| Capital expenditure | -$174.00M | -$200.00M | -$213.00M | -$211.00M | -$208.00M | +13.0% |
| Investing cash flow | -$353.00M | $89.00M | $660.00M | $1.24B | -$899.00M | -496.6% |
| Share buybacks | -$4.00M | -$29.00M | -$2.00M | $0 | -$432.00M | +86.2% |
| Financing cash flow | -$259.00M | -$1.06B | -$187.00M | -$10.00M | -$1.17B | +75.6% |
| Free cash flow | $3.42B | $4.17B | $224.00M | $1.15B | $1.58B | -18.0% |
| End cash position | $24.25B | $21.35B | $17.96B | $17.18B | $14.60B | +13.6% |
Options analytics
Put / call volume
0.72
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
35.00
-45.8% from spot
ATM implied vol
1.6%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
1.43K
Contracts, this expiry
Put volume
1.03K
Contracts, this expiry
Heaviest call OI
35.00
0 contracts
Heaviest put OI
35.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.08 | 2.51 | +132.6% |
| Mar 2026 | 2.13 | 3.37 | +57.9% |
| Dec 2025 | -1.22 | -1.19 | +2.5% |
| Sep 2025 | -0.16 | 0.50 | +404.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.10 | 19 | $46.95B | -5.5% |
| Next quarter | -1.09 | 19 | $45.43B | -8.6% |
| Current year | 4.88 | 21 | $195.92B | +0.6% |
| Next year | 5.35 | 21 | $192.75B | -1.6% |
Analyst targets & ownership
Mean target$71.78
High target$85.00
Low target$56.00
Implied upside11.09%
Analyst count18
ConsensusBUY
Strong buy / Buy1 / 7
Hold12
Sell / Strong sell1 / 0
Held by insiders0.39%
Held by institutions101.61%
Institutions holding1.41K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
62.56
+3.28% from price
SMA 20
64.25
+0.56% from price
SMA 50
64.74
-0.20% from price
SMA 100
64.03
+0.90% from price
SMA 200
53.04
+21.80% from price
EMA 12
63.45
+1.83% from price
EMA 26
64.08
+0.83% from price
EMA 50
64.10
+0.79% from price
RSI (14)
51.9
Neutral
MACD (12,26,9)
-0.63
Hist 0.05
ATR (14)
1.89
2.93% of price
Realised vol 30D
30.9%
Annualised
Bollinger upper
68.67
20, 2σ
Bollinger lower
59.83
20, 2σ
50 / 200 cross
Golden
64.74 vs 53.04
Trend bias
Above 200
+21.80%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.38
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
30.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-32.7%
Peak to trough
Max drawdown 5Y
-74.1%
Peak to trough
ATR 14
1.89
2.93% of price
Beta (reported)
1.13
5Y monthly, from filing
Short interest
Shares short
14.13M
Prior 13.27M
Change vs prior
+6.5%
Shorts adding
% of float
3.28%
Normal
% of shares out
2.86%
Against total outstanding
Days to cover
3.6
Liquid
Float
463.68M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 11, 26 | Argus Research | UPGRADE | Hold | Buy |
| Aug 4, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Aug 3, 26 | Bernstein | MAINTAINED | Outperform | Outperform |
| Jul 29, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 29, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Jul 14, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Jul 14, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 13, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 9, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jul 7, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Jun 23, 26 | RBC Capital | INITIATED | — | Sector Perform |
| Jun 8, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateFeb 7, 2019
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-16
Corporate Changes & Voting Matters
8-K · 2026-08-17
Corporate Changes & Voting Matters
8-K · 2026-07-29
Periodic Financial Reports
10-Q · 2026-07-28
Corporate Changes & Voting Matters
8-K · 2026-06-22
Corporate Changes & Voting Matters
8-K · 2026-05-15
Corporate Changes & Voting Matters
8-K · 2026-04-28
Proxy Statements
DEF 14A · 2026-03-26
Headlines
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated
Zacks · 15h ago
Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3
Zacks · 18h ago
Oscar Health Trading at a Premium: Why Should You Still Buy It?
Zacks · 1d ago
UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure
Zacks · 2d ago
Are Investors Undervaluing Centene (CNC) Right Now?
Zacks · 2d ago
The Insurance Industry Is Shedding Jobs. It’s Not All About AI.
Barrons.com · 4d ago
UnitedHealth and Humana cutting Medicare Advantage plans in 2027
Quartz · 5d ago
Centene (CNC): Pricing Actions and Profit Stabilization Drive Earnings Recovery
Insider Monkey · 6d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.